Status:
COMPLETED
Comparison of Lower Limb Endovascular Interventions With and Without the EndoNaut Workstation
Lead Sponsor:
Therenva
Collaborating Sponsors:
CH Libourne
Conditions:
Peripheral Arterial Disease
Eligibility:
All Genders
18+ years
Brief Summary
To demonstrate that the use of EndoNaut for endovascular procedures on the femoropopliteal axis has a clinical impact for the patient (decrease in irradiation and the volume of contrast product) as we...
Detailed Description
Peripheral artery disease (PAD) is characterized by a narrowing of the size of arteries, which resulting in a loss of hemodynamic load. Endovascular (or percutaneous) procedures performed at the infra...
Eligibility Criteria
Inclusion
- Patients with peripheral arterial disease of the lower limbs, all clinical stages, lesions of the femoro-popliteal stage and candidates for endovascular treatment of these lesions.
- Major patients
- Patients not opposed to their participation in the study
Exclusion
- \- Patients requiring conventional surgical revascularization.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04709991
Start Date
January 1 2019
End Date
July 1 2021
Last Update
October 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CH Libourne
Libourne, France